Banque Cantonale Vaudoise Sells 3,471 Shares of Intuitive Surgical, Inc. $ISRG

Banque Cantonale Vaudoise cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.4% during the 4th quarter, Holdings Channel reports. The firm owned 11,345 shares of the medical equipment provider’s stock after selling 3,471 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Intuitive Surgical were worth $6,426,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in ISRG. Holos Integrated Wealth LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. grew its holdings in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $27,000. Olistico Wealth LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, Caitlin John LLC bought a new stake in Intuitive Surgical during the third quarter worth $30,000. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Bank of America cut their price objective on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. JPMorgan Chase & Co. cut their target price on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Evercore reduced their target price on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a report on Monday, April 6th. Finally, Raymond James Financial decreased their price target on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $579.33.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Amy L. Ladd sold 500 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director directly owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 5,647 shares of company stock worth $2,760,359. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

ISRG stock opened at $441.58 on Wednesday. Intuitive Surgical, Inc. has a one year low of $417.74 and a one year high of $603.88. The stock has a market cap of $156.39 billion, a PE ratio of 53.52, a P/E/G ratio of 3.51 and a beta of 1.51. The firm has a 50 day simple moving average of $461.52 and a two-hundred day simple moving average of $512.36.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same period in the previous year, the business earned $1.81 earnings per share. The firm’s quarterly revenue was up 23.0% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.